Comparison 10. Aspirin versus ketorolac.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
10.1 Adequate pain relief as reported by the woman	1	90	Risk Ratio (M‐H, Fixed, 95% CI)	0.95 [0.81, 1.11]
10.1.1 Aspirin 650 mg versus Ketorolac 5 mg	1	45	Risk Ratio (M‐H, Fixed, 95% CI)	1.00 [0.78, 1.28]
10.1.2 Aspirin 650 mg versus Ketorolac 10 mg	1	45	Risk Ratio (M‐H, Fixed, 95% CI)	0.90 [0.73, 1.11]
10.2 Need for additional pain relief	1	90	Risk Ratio (M‐H, Fixed, 95% CI)	1.18 [0.16, 8.52]
10.2.1 Aspirin 650 mg versus Ketorolac 5 mg	1	45	Risk Ratio (M‐H, Fixed, 95% CI)	2.00 [0.13, 29.81]
10.2.2 Aspirin 650 mg versus Ketorolac 10 mg	1	45	Risk Ratio (M‐H, Fixed, 95% CI)	0.65 [0.03, 14.97]
10.3 Maternal adverse events	1	90	Risk Ratio (M‐H, Fixed, 95% CI)	1.69 [0.86, 3.31]
10.3.1 Aspirin 650 mg versus Ketorolac 5 mg	1	45	Risk Ratio (M‐H, Fixed, 95% CI)	1.67 [0.61, 4.59]
10.3.2 Aspirin 650 mg versus Ketorolac 10 mg	1	45	Risk Ratio (M‐H, Fixed, 95% CI)	1.71 [0.70, 4.20]